Form 4 for IBRX ImmunityBio, Inc.

Accepted 2021-10-08 00:00:00 ET · period of report 2021-10-08 · accession 0001326110-21-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2021-10-08	2021-10-08	IBRX	Adcock Richard	CEO, Pres, Dir	P - Purchase	$8.81	+1,930	7	New	+$17.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-10-08	P	A	1,923	$8.81	1,930	I See footnote	—	—	(F1) Shares held by girlfriend living in the same household as the Reporting Person. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
2	Common	Common Stock	2021-10-08	P	A	7	$9.00	7	I See footnote	—	—	(F1) Shares held by girlfriend living in the same household as the Reporting Person. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.